Brief: Senzime Sees Continued High Demand On Main Markets For 2023
28/04/2023 07:38
April 28 (Reuters) - Senzime AB (publ) SEZI.ST :
* OUR OUTLOOK FOR 2025 IS UNCHANGED
* FOR 2023, WE ANTICIPATE CONTINUED HIGH DEMAND ON OUR MAIN
MARKETS, AND SIGNIFICANTLY BETTER SALES THAN IN 2022.
Source text for Eikon: ID:nMFNbj3D1c
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona